Skip to main content

Advertisement

SpringerLink
Log in

Prognostic Significance of the Number of Removed Lymph Nodes in Pathologic Node-Negative Non-small Cell Lung Cancer

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

Major lung resection combined with mediastinal lymph node dissection is the standard operation for early-stage non-small cell lung cancer (NSCLC), and lymph node staging is the main predictor of long-term survival. This study aims to identify the prognostic significance of the number of removed lymph nodes in patients with pathologic node-negative (pN0) non-small cell lung cancer (NSCLC). Five hundred thirty-six stage pN0 NSCLC patients, received curative resection between January 2004 and July 2011, were enrolled in this retrospective study. The prognostic factors including the number of removed lymph nodes and clinicopathological characteristics were analyzed. Increasing number of removed lymph nodes was associated with better overall survival (OS) (p = 0.009) of stage pN0 NSCLC patients. The number (p < 0.001) and stations (p = 0.011) of removed lymph nodes, tumor stage (p < 0.001), as well as tumor size (p = 0.017), were independent prognostic factors of stage pN0 NSCLC patients. Overall, patients with more than three stations of examined mediastinal lymph node (p = 0.001) owned better 5-year OS. In subgroup analyses, patients of stage T1 and T2 with more than 11 removed lymph nodes (p = 0.033 and p = 0.011, respectively), and patients of stage T3 with more than 16 removed lymph nodes (p < 0.001) obtained improvements of 5-year OS. The number of removed lymph nodes was not correlated with the incidence of postoperative complications (p = 0.130). The number of removed lymph nodes is an independent prognostic factor for stage pN0 NSCLC patients. Sufficient lymph node dissection is recommended to improve the prognosis of patients with pN0 NSCLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Le Chevalier T (2010) Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going? Ann Oncol 21(Suppl 7):vii196–vii198

    PubMed  Google Scholar 

  2. Groome PA, Bolejack V, Crowley JJ, Kennedy C, Krasnik M, Sobin LH, Goldstraw P, IASLC International Staging Committee, Cancer Research and Biostatistics, Observers to the Committee, Participating Institutions (2007) The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2:694–705

    Article  PubMed  Google Scholar 

  3. Osarogiagbon RU, Yu X (2012) Mediastinal lymph node examination and survival in resected early-stage non-small-cell lung cancer in the surveillance, epidemiology, and end results database. J Thorac Oncol 7:1798–1806

    Article  CAS  PubMed  Google Scholar 

  4. Ramirez RA, Wang CG, Miller LE, Adair CA, Berry A, Yu X et al (2012) Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer. J Clin Oncol 30:2823–2828

    Article  PubMed  Google Scholar 

  5. Hsu PK, Huang CS, Wang BY, Wu YC, Chou TY, Hsu WH (2013) The prognostic value of the number of negative lymph nodes in esophageal cancer patients after transthoracic resection. Ann Thorac Surg 96:995–1001

    Article  PubMed  Google Scholar 

  6. Huang CM, Lin JX, Zheng CH, Li P, Xie JW, Lin BJ (2011) Effect of negative lymph node count on survival for gastric cancer after curative distal gastrectomy. Eur J Surg Oncol 37:481–487

    Article  PubMed  Google Scholar 

  7. Donington J, Ferguson M, Mazzone P, Handy J Jr, Schuchert M, Fernando H et al (2012) American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. Chest 142:1620–1635

    Article  PubMed  Google Scholar 

  8. Takenaka T, Katsura M, Shikada Y, Takeo S (2013) Outcome of surgical resection as a first line therapy in T3 non-small cell lung cancer patients. World J Surg 37:2574–2580

    Article  PubMed  Google Scholar 

  9. Vielva LR, Jaen MW, Alcacer JA, Cardona MC (2014) State of the art in surgery for early stage NSCLC—does the number of resected lymph nodes matter? Transl Lung Cancer Res 3:95–99

    PubMed  PubMed Central  Google Scholar 

  10. De Leyn P, Lardinois D, Van Schil P, Rami-Porta R, Passlick B, Zielinski M et al (2007) European trends in preoperative and intraoperative nodal staging: ESTS guidelines. J Thorac Oncol 2:357–361

    Article  PubMed  Google Scholar 

  11. Ludwig MS, Goodman M, Miller DL, Johnstone PA (2005) Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest 128:1545–1550

    Article  PubMed  Google Scholar 

  12. Varlotto JM, Recht A, Nikolov M, Flickinger JC, Decamp MM (2009) Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer. Cancer 115:851–858

    Article  PubMed  Google Scholar 

  13. Ou SH, Zell JA (2008) Prognostic significance of the number of lymph nodes removed at lobectomy in stage IA non-small cell lung cancer. J Thorac Oncol 3:880–886

    Article  PubMed  Google Scholar 

  14. Wu YC, Lin CF, Hsu WH, Huang BS, Huang MH, Wang LS (2003) Long-term results of pathological stage I non-small cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control. Eur J Cardio-Thorac Surg 24:994–1001

    Article  Google Scholar 

  15. Osarogiagbon RU, Ogbata O, Yu X (2014) Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non-small cell lung cancer. Ann Thorac Surg 97:385–393

    Article  PubMed  Google Scholar 

  16. Li SH, Wang Z, Liu XY, Liu FY (2008) Gene diagnosis and prognostic significance of lymph node micrometastasis after complete resection of histologically node-negative non-small cell lung cancer. World J Surg 32:1651–1656

    Article  PubMed  Google Scholar 

  17. Lardinois D, De Leyn P, Van Schil P, Porta RR, Waller D, Passlick B et al (2006) ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardio-Thorac Surg 30:787–792

    Article  Google Scholar 

  18. Allen JW, Farooq A, O'Brien TF, Osarogiagbon RU (2011) Quality of surgical resection for nonsmall cell lung cancer in a US metropolitan area. Cancer 117:134–142

    Article  PubMed  Google Scholar 

  19. Verhagen AF, Schoenmakers MC, Barendregt W, Smit H, van Boven WJ, Looijen M et al (2012) Completeness of lung cancer surgery: is mediastinal dissection common practice? Eur J Cardio-Thorac Surg 41:834–838

    Article  Google Scholar 

  20. Sugi K, Nawata K, Fujita N, Ueda K, Tanaka T, Matsuoka T, Kaneda Y, Esato K (1998) Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg 22:290–294 discussion 94-5

    Article  CAS  PubMed  Google Scholar 

  21. Darling GE, Allen MS, Decker PA, Ballman K, Malthaner RA, Inculet RI, Jones DR, McKenna RJ, Landreneau RJ, Rusch VW, Putnam JB Jr (2011) Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg 141:662–670

    Article  PubMed  PubMed Central  Google Scholar 

  22. Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC (2013) Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e278S–e313S

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei, China

    Xian-Ning Wu, Ming-Ran Xie, Shi-Bin Xu, Jun Wang, Xian-Liang Jiang & Mei-Qing Xu

Authors
  1. Xian-Ning Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ming-Ran Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shi-Bin Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xian-Liang Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mei-Qing Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xian-Ning Wu or Mei-Qing Xu.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, XN., Xie, MR., Xu, SB. et al. Prognostic Significance of the Number of Removed Lymph Nodes in Pathologic Node-Negative Non-small Cell Lung Cancer. Indian J Surg 81, 137–143 (2019). https://doi.org/10.1007/s12262-018-1746-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-018-1746-z

Keywords

Search

Navigation